Emad B. Basalious

2.4k total citations
58 papers, 1.9k citations indexed

About

Emad B. Basalious is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Emad B. Basalious has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pharmaceutical Science, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Emad B. Basalious's work include Advanced Drug Delivery Systems (26 papers), Drug Solubulity and Delivery Systems (24 papers) and Advancements in Transdermal Drug Delivery (15 papers). Emad B. Basalious is often cited by papers focused on Advanced Drug Delivery Systems (26 papers), Drug Solubulity and Delivery Systems (24 papers) and Advancements in Transdermal Drug Delivery (15 papers). Emad B. Basalious collaborates with scholars based in Egypt, United States and China. Emad B. Basalious's co-authors include Omaima N. El‐Gazayerly, Mamdouh R. Rezk, Shaimaa M. Badr-Eldin, Ehab R. Bendas, Rehab Nabil Shamma, Soad A. Yehia, Nermeen A. Elkasabgy, Mohamed A. El-Nabarawi, Shahinaze A. Fouad and Saadia A. Tayel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Emad B. Basalious

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emad B. Basalious Egypt 26 996 397 214 177 174 58 1.9k
Ehab R. Bendas Egypt 19 849 0.9× 275 0.7× 136 0.6× 84 0.5× 89 0.5× 34 1.4k
Myung Joo Kang South Korea 26 850 0.9× 469 1.2× 394 1.8× 25 0.1× 101 0.6× 109 1.9k
Abid Mehmood Yousaf Pakistan 28 930 0.9× 260 0.7× 425 2.0× 24 0.1× 105 0.6× 74 1.9k
Padma V. Devarajan India 31 857 0.9× 1.0k 2.5× 929 4.3× 103 0.6× 114 0.7× 91 3.0k
Young Wook Choi South Korea 33 1.5k 1.5× 894 2.3× 529 2.5× 30 0.2× 163 0.9× 133 3.1k
Yue Yuan China 23 392 0.4× 404 1.0× 294 1.4× 30 0.2× 101 0.6× 75 1.8k
Dengning Xia China 24 1.1k 1.1× 495 1.2× 409 1.9× 21 0.1× 68 0.4× 44 1.8k
Joseph A. Fix United States 23 1.1k 1.1× 398 1.0× 241 1.1× 28 0.2× 77 0.4× 49 2.2k
Mohamed A. El-Nabarawi Egypt 29 2.0k 2.0× 537 1.4× 420 2.0× 30 0.2× 37 0.2× 168 3.1k

Countries citing papers authored by Emad B. Basalious

Since Specialization
Citations

This map shows the geographic impact of Emad B. Basalious's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emad B. Basalious with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emad B. Basalious more than expected).

Fields of papers citing papers by Emad B. Basalious

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emad B. Basalious. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emad B. Basalious. The network helps show where Emad B. Basalious may publish in the future.

Co-authorship network of co-authors of Emad B. Basalious

This figure shows the co-authorship network connecting the top 25 collaborators of Emad B. Basalious. A scholar is included among the top collaborators of Emad B. Basalious based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emad B. Basalious. Emad B. Basalious is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Basalious, Emad B., et al.. (2024). Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study. Drug Delivery and Translational Research. 14(9). 2539–2557. 19 indexed citations
3.
Salama, Alaa H., et al.. (2024). Terpene-augmented novasomal gels for the sustainment of rasagiline mesylate delivery; A new approach for treating Parkinson's disease induced by rotenone in rats. Journal of Drug Delivery Science and Technology. 92. 105369–105369. 2 indexed citations
4.
Hamdy, Nadia Μ., Emad B. Basalious, Maha Nasr, et al.. (2024). Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine. Current Medical Research and Opinion. 40(11). 1943–1961. 40 indexed citations
5.
Basalious, Emad B., et al.. (2024). Lipid nanocapsules: A Novel Strategy for Brain Targeting via Nasal Administration. Journal of Research in Pharmacy. 28(2)(28(2)). 545–559. 3 indexed citations
6.
7.
Basalious, Emad B., et al.. (2023). Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine TargetingNon-coding Epigenetics to Improve Current and Future Therapeutics. Current Pharmaceutical Design. 30(1). 31–47. 25 indexed citations
8.
Afifi, Ahmed, Motawa E. El-Houseini, Mohamed Ezzelarab, et al.. (2023). The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study. Discover Oncology. 14(1). 169–169. 6 indexed citations
9.
Hamdy, Nadia Μ., et al.. (2022). Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?. The EPMA Journal. 13(2). 261–284. 14 indexed citations
10.
11.
12.
Hamdy, Nadia Μ., et al.. (2022). Insights on the Dynamic Innovative Tumor Targeted-Nanoparticles-Based Drug Delivery Systems Activation Techniques. International Journal of Nanomedicine. Volume 17. 6131–6155. 17 indexed citations
13.
Azzazy, Hassan Mohamed El-Said, et al.. (2020). Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study. Materials Science and Engineering C. 116. 111236–111236. 29 indexed citations
14.
Elkheshen, Seham A., Azza A. Mahmoud, Emad B. Basalious, et al.. (2020). In-situ forming chitosan implant-loaded with raloxifene hydrochloride and bioactive glass nanoparticles for treatment of bone injuries: Formulation and biological evaluation in animal model. International Journal of Pharmaceutics. 580. 119213–119213. 43 indexed citations
15.
Elkasabgy, Nermeen A., et al.. (2019). Freeze-Dried Self-Nanoemulsifying Self-Nanosuspension (SNESNS): a New Approach for the Preparation of a Highly Drug-Loaded Dosage Form. AAPS PharmSciTech. 20(7). 258–258. 35 indexed citations
16.
Rezk, Mamdouh R., et al.. (2016). Quantification of sofosbuvir and ledipasvir in human plasma by UPLC–MS/MS method: Application to fasting and fed bioequivalence studies. Journal of Chromatography B. 1028. 63–70. 54 indexed citations
17.
18.
El-Laithy, Hanan M., et al.. (2015). Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery. International Journal of Pharmaceutics. 490(1-2). 146–154. 62 indexed citations
19.
Shamma, Rehab Nabil, et al.. (2010). Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration. International Journal of Pharmaceutics. 405(1-2). 102–112. 18 indexed citations
20.
Yehia, Soad A., Omaima N. El‐Gazayerly, & Emad B. Basalious. (2009). Fluconazole Mucoadhesive Buccal Films: In Vitro/In Vivo Performance. Current Drug Delivery. 6(1). 17–27. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ehab R. Bendas Breakdown of academic impact, for papers by Myung Joo Kang Breakdown of academic impact, for papers by Abid Mehmood Yousaf Breakdown of academic impact, for papers by Padma V. Devarajan Breakdown of academic impact, for papers by Young Wook Choi Breakdown of academic impact, for papers by Yue Yuan Breakdown of academic impact, for papers by Dengning Xia Breakdown of academic impact, for papers by Joseph A. Fix Breakdown of academic impact, for papers by Mohamed A. El-Nabarawi
Rankless by CCL
2026